Sign up for your FREE email newsletter  +


JRS PHARMA to offer povidone products

Strategic alliance expands company's product portfolio

Ingredients | Finance | Asia

Designer protein gives new hope to scientists studying Alzheimer’s disease

A new protein, which will help scientists to understand why nerve cells die in people with Alzheimer’s disease, has been designed in a University of Sussex laboratory

Ingredients | R and D | Therapeutic Sector | Mental Health

Why supply chain transparency and data integrity are crucial for pharma quality

Robert Gaertner from Veeva Systems makes the case that cloud-based collaboration increases productivity and transparency, and reduces quality risks in the life sciences supply chain

Regulatory | Information Technology

PPMA Total Show 2016: A Q&A with Group Exhibition Manager David Harrison

A great opportunity for businesses to get their brand, products and equipment in front of a high profile audience and celebrate the innovation that the industry has to offer

Packaging | Europe | Manufacturing and Equipment

Peli BioThermal announces Asia expansion with additional distribution partners

New distributors enhance customer support by offering local hours, local language and local service and inventory at the point of final distribution


ADCs: a more effective, less harmful, targeted approach

Antibody-drug conjugates could hold the key to delivering highly potent anticancer drugs more accurately to the tumour site with less damage to healthy cells

Regulatory | Drug Delivery | R and D | Therapeutic Sector

Crown Bioscience expands US operations

Company establishes Center of Excellence for Oncology in San Diego

Design and Build | North America | R and D | Therapeutic Sector

Evaluation and safe handling of ADCs and their toxic payloads: Part 2

In this second article of a two-part series, John Farris, CIH, and Robert Sussman, PhD DABT, SafeBridge Consultants, cover the safe handling of antibody-drug conjugates in pharmaceutical facilities and the control measures needed to protect workers from exposure risks

Containment | Regulatory | Manufacturing and Equipment

EMA proposes to revise guidance on first-in-human clinical trials

Comments invited on a concept paper on changes intended to support best practices

Europe | Regulatory

Factors to consider when choosing neutralisers for use in growth media

Environmental Monitoring is a GMP requirement to ensure drug products are made in a non-contaminating environment. Andrew Ramage and Harshad Joshi, Cherwell Laboratories, give a scientific and regulatory perspective on considerations when using neutralisers in growth media

Europe | Measurement and Analysis

In the Press

Subscriber Sign In

Why subscribe?

Most Popular


Most Popular Companies

Recent Features